Tarceva and Hair texture abnormal - a phase IV clinical study of FDA data

Summary:

Hair texture abnormal is reported as a side effect among people who take Tarceva (erlotinib hydrochloride), especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months also take Taxotere, and have Lung neoplasm malignant.

The phase IV clinical study analyzes which people have Hair texture abnormal when taking Tarceva. It is created by eHealthMe based on reports of 30,795 people who have side effects when taking Tarceva from the FDA, and is updated regularly.

What is Tarceva?

Tarceva has active ingredients of erlotinib hydrochloride. It is often used in lung cancer. eHealthMe is studying from 31,036 Tarceva users. Check the latest studies of Tarceva.

What is Hair texture abnormal?

Hair texture abnormal is found to be associated with 727 drugs and 655 conditions by eHealthMe. Check the latest studies of Hair texture abnormal.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

30,795 people reported to have side effects when taking Tarceva.
Among them, 126 people (0.41%) have Hair texture abnormal.

Could Tarceva cause Hair texture abnormal?

Among these 126 people:

How long have people been on Tarceva when they have Hair texture abnormal? *

Click here to view more results

What is the gender of people who have Hair texture abnormal when taking Tarceva? *

Click here to view

* Approximation only. Some reports may have incomplete information.

Do you take Tarceva and have Hair texture abnormal?

- Check whether Hair texture abnormal is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Tarceva:

Tarceva (31,036 reports)

Hair texture abnormal treatments and more:

Hair texture abnormal (18,699 reports)

How severe was Hair texture abnormal and when was it recovered:

Hair texture abnormal in Tarceva

Expand to all the drugs that have ingredients of erlotinib hydrochloride:

Hair texture abnormal and drugs with ingredients of erlotinib hydrochloride

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Tarceva:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hair texture abnormal:

Hair texture abnormal (727 drugs)

Browse all the conditions that are associated with Hair texture abnormal:

Hair texture abnormal (655 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on erlotinib hydrochloride (the active ingredients of Tarceva) and Tarceva (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.